Looking at top Wall Street opinions, Jaguar Health, Inc. (NASDAQ: JAGX) has recently made its way into the research list of Rodman & Renshaw – signaling that their analyst’s rating adjustment is noteworthy. In the past six months and three months of trading, shares of Jaguar Health, Inc. (JAGX) have moved by -51.67% and -6.78%, respectively.
Brokerage Updates Related to Jaguar Health, Inc. (JAGX) Stock
Not a Single analyst have given underperform rating or sell rating, and 0 have given a rating of Buy or better. Based on the 1 stock market experts following this company, the average 12-month price target is $1.25. Moreover, individual price targets range between $1.00-$1.00. With its recent move to $1.00, we can see that these firms project this stock will loss by -90.39% in one year.
Updates from Jaguar Health, Inc. (JAGX) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 9.57% rise since the beginning of the calendar year. A Director at Jaguar Health, Inc. (JAGX) bought some of its shares in a transaction that was finalized on Oct 04. Nantucket Investments Ltd sold 325,615 shares of the organization’s stock at $1.83 apiece and racked up $595,875 in earnings from the sale. Now, Nantucket Investments Ltd holds 0 shares of the company following the exchange. A CEO and President of the organization named CONTE LISA A, was engaged in a transaction that occurred on Jul 18 that managed to be worth $1,669 from the purchase of 1,500 common shares at a price of $1.11 per individual share.
Jaguar Health, Inc. (NASDAQ:JAGX) Results in the Pipeline
The next scheduled release of financial results for Jaguar Health, Inc. will be for the Sep-17 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be -$1.95. In the same vein, they expect sales for the quarter to amount to $1.61 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $1.10 million in revenue alongside EPS at -$0.90. On average, the analyst projection was calling for $0.90 million with -$1.80 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $0.03 million, with earnings per share ending up at -$4.20.
Delta Air Lines, Inc. (NYSE:DAL) experienced a gain of 0.55% from the closing price in the previous trading day. That boost the price to $58.43 per share, as observed on December 31st, 1969, at a time when the total trading volume reached 4,928,340 shares of stock – compared to the typical average of 8.00M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $63.37.
Pricing Indications for Delta Air Lines, Inc. (DAL)
This organization has had a price-to-earnings ratio of 10.30 in the last year. Meanwhile, it gained 52.16 from its observable 50-day simple moving average. Right at this moment, the per-share value is 9.64% higher than the mean per-share price over the last 200 days in the market.
Delta Air Lines, Inc. (NYSE:DAL) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 7 have a Buy rating, 9 have an outperform rating, while 5 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 1.90 , based on information from Thomson Reuters.
DAL Stock Value Potential
In trading activity as of late, this stock’s value was 53.34 up from its 200 day moving average, while also 12.37% up when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $56.00-$90.00. The market value for the entire organization reached 39.67B. In the last trading session, the price ended the day at $58.11. The institutional holdings related to this organization account for 0.30%, and the Beta factor is now 1.08. This company’s RSI (Relative Strength Index) managed to hit 71.51.
Delta Air Lines, Inc. (NYSE:DAL) Analyst Points of Focus
Delta Air Lines, Inc. (DAL) has found itself inside of Imperial Capital’s research list, so their analyst rating adjustment is worth taking note of. This stock was Reiterated to In-line, by Imperial Capital, as garnered from a news report on Thursday April 11th, 2019. An additional helpful research note was sent out by BofA/Merrill’s on Thursday April 4th, 2019. The brokerage decided to reiterated DAL to Neutral.